Skip to main content
. 2015 Mar 30;290(19):12210–12221. doi: 10.1074/jbc.M115.646893

FIGURE 4.

FIGURE 4.

EHD3 is required for proper CaV3.1 and CaV3.2 targeting in atrial myocytes. A and B, compared with WT atrial myocytes, CaV3.1 and CaV3.2 are mis-localized in EHD3 cKO atrial myocytes. Ankyrin-B is utilized as a control for cell quality. (Scale bar = 10 μm.)